5 November 2024 - Pharmaceutical companies whose medicines have been indefinitely delayed are being charged $200,000 per application despite no services being provided, as patient outrage grows.

Patient advisory groups left in the dark over 45 medicines left off the agenda of the next PBAC meeting have demanded the Albanese Government intervene. Cancer treatments and chronic disease medications are among the drugs deferred in the surprise decision, with delays of at least four months expected to their potential PBS listing.

Read The Australian article